Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: The OMERACT 9 v2 criteria

Walter P. Maksymowych, Robert Landewé, Paul Peter Tak, Christopher J. Ritchlin, Mikkel Østergaard, Philip J. Mease, Hani El-Gabalawy, Patrick Garnero, Dafna D. Gladman, Oliver FitzGerald, Daniel Aletaha, Vivien P. Bykerk, Joan M. Bathon, Silje W. Syversen, Maarten Boers, Piet Geusens, Robert D. Inman, Virginia B. Kraus, Tore K. Kvien, William J. TaylorGeorge A. Wells, Désirée Van Der Heijde

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: The OMERACT 9 v2 criteria'. Together they form a unique fingerprint.

Medicine & Life Sciences